Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
Clinical trial NCT02081118 · COMPLETED
Trial details
- NCT number
- NCT02081118
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2015-03-01
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.